Odalys Torné Escudé, DVM graduated with a PhD in Comparative Biomedical Sciences in May 2024. She will be greatly missed, though we wish her the best in whatever exciting new chapters are ahead. Here’s to …
News
Congratulations Kazu!
Kazu received funding from ACVO VAF for his proposal, “Evaluating a novel topical EP2 receptor agonist as a treatment for feline glaucoma”. Work generated by this study may lead to greater treatment options for cats …
Career Starter Grant for Kazu!
Congratulations to post-doc trainee, Dr Kazuya Oikawa on being awarded a Career Starter grant from the Knights Templar Eye Foundation to study neuroinflammation in pediatric glaucoma. A first step on the path towards an independent …
Moving on….
Congratulations and good luck to former research intern Shawna Gloe and to former student research assistant Hannah Walleck as they leave the lab to start Medical School and Optometry School, respectively. We are grateful for …
Congratulations Travel Awardees!
Post-doc Kazu Oikawa and PhD student Odalys Torne both received travel awards to attend the ISER / BrightFocus Foundation Glaucoma Symposium in Atlanta, Georgia in fall 2021. It will be exciting to travel again and …
Kara Vogel awarded Kenzi Valentyn vision research grant
Congratulations to Kara on securing a coveted Kenzi Valentyn award! The McPherson Eye Research Institute established this program in 2017 to support the career development and bright ideas of trainee members. Kara will use her …
Gillian McLellan named new Tim and Nancy Speaker Chair in Canine Health
The UW School of Veterinary Medicine announced that Dr. McLellan will be the inaugural recipient of the Tim and Nancy Speaker Chair in Canine Health. The Speaker Chair was established earlier this spring by Tim …
An important role for neuroinflammation in glaucoma
Kazu Oikawa, a PhD dissertator in the McLellan lab, identified inflammatory responses as playing an important early role in damage to the optic nerve caused by glaucoma. Armed with this knowledge, we will be better …
Important new insight into causes of vision problems in some patients being treated with anti-epileptic drug
A recent publication from our lab provides important new clues to explain vision problems reported in patients receiving the anti-epileptic drug, vigabatrin. Read our paper here
New study published in PNAS supports test for effectiveness of new Multiple Sclerosis treatments
In this collaborative study with Dr Ian Duncan’s lab and Dr James N Verhoeve, published by PNAS in December, 2019, it is confirmed that delays in visual evoked potentials can be used as an indirect measure …